Bart Spiessens

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S”.

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

npj Vaccines(2020)10.1038/s41541-020-00261-9

N/A

0DataRank · unranked

75 citations

Jenny Hendriks, Thierry Van Effelterre, Bart Spiessens, Liesbeth Dekking, Laura Solforosi +24 more

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

npj Vaccines(2022)10.1038/s41541-022-00564-z

N/A

0DataRank · unranked

21 citations

Maarten Leyssen, Dirk Heerwegh, Bart Spiessens, Cynthia Robinson, Jeroen N. Stoop +13 more

Adopting the estimand framework in prophylactic vaccine trials

Vaccine(2025)10.1016/j.vaccine.2025.127645

N/A

0DataRank · unranked

1 citations

Naveen Karkada, Ye Yang, J. C. Scott, Lei Huang, Florian Klinglmüller +11 more